Janssen Lindy J F, Lo-A-Njoe Shirley M, Ten Pas Charlotte, Duits Ashley J
Department of Pediatrics Curacao Medical Center Willemstad Curacao Department of Pediatrics, Curacao Medical Center, Willemstad, Curacao.
Red Cross Blood Bank Foundation Willemstad Curacao Red Cross Blood Bank Foundation, Willemstad, Curacao.
Rev Panam Salud Publica. 2023 Aug 21;47:e129. doi: 10.26633/RPSP.2023.129. eCollection 2023.
This study aimed to describe and critically evaluate the COVID-19 vaccination program for high-risk children in Curacao and provide information about important factors such as parents' vaccination hesitancy and effective strategies for communicating and delivering information about vaccination.
This was a cross-sectional study. It was important to identify children aged 12-17 years who were at high risk of severe COVID-19 infection because of the limited medical facilities on the island; children considered to be at high risk were those with diseases such as obesity, hypertension or diabetes mellitus type 2. These children or their caregivers were invited by their pediatricians to be vaccinated as part of a program run by the Public Health Department of Curacao. These high-risk patients were vaccinated between 30 May 2021 and 25 February 2022 in designated child-friendly spaces, with a pediatrician present for guidance and reassurance. Children received the Pfizer-BioNTech COVID-19 vaccine at the recommended dose for their age. The primary outcome was a description and evaluation of the attendance for vaccination. The secondary outcomes were side effects after vaccination for the age groups 12-15 years and 16-17 years. Reasons for refusal or nonadherence were also registered.
Altogether 51% (24/47) of those aged 16-17 years who were invited were vaccinated compared with 42% (26/69) of those aged 12-15 years who were invited. Altogether, 46% of these high-risk children were vaccinated compared with 48% of children aged 12-17 years without risk factors. In our population, most patients did not experience any side effects and if they did, the side effects were mild. No cases of myocarditis or pericarditis were observed. A lack of trust in the vaccine and a lack of prioritization of vaccination when scheduling daily activities were important factors in refusal and nonadherence.
To organize a successful vaccination program in a small community with limited resources for treating high-risk children it is crucial for medical professionals to provide reliable information. Public health initiatives should focus on assuaging parents' fears about vaccines. In addition, ensuring there is good cooperation between doctors and the Public Health Department can help to make implementation successful. Finally, involving pediatricians and using dedicated areas for vaccinating children can help build trust with parents and caregivers.
本研究旨在描述并批判性评估库拉索岛针对高危儿童的新冠疫苗接种计划,并提供有关重要因素的信息,如家长对疫苗接种的犹豫态度以及传达和提供疫苗接种信息的有效策略。
这是一项横断面研究。由于该岛医疗设施有限,确定12至17岁因新冠病毒严重感染风险高的儿童非常重要;被认为高危的儿童是那些患有肥胖症、高血压或2型糖尿病等疾病的儿童。这些儿童或其照顾者由他们的儿科医生邀请,作为库拉索岛公共卫生部开展的一项计划的一部分进行疫苗接种。这些高危患者于2021年5月30日至2022年2月25日在指定的儿童友好空间接种疫苗,有儿科医生在场提供指导和安抚。儿童按照其年龄推荐剂量接种辉瑞 - 生物科技新冠疫苗。主要结果是对疫苗接种出勤情况的描述和评估。次要结果是12至15岁和16至17岁年龄组接种疫苗后的副作用。拒绝或不依从的原因也进行了记录。
被邀请的16至17岁人群中,共有51%(24/47)接种了疫苗,而被邀请的12至15岁人群中这一比例为42%(26/69)。总体而言,这些高危儿童中有46%接种了疫苗,而无风险因素的12至17岁儿童中这一比例为48%。在我们的研究对象中,大多数患者没有出现任何副作用,即便出现,副作用也很轻微。未观察到心肌炎或心包炎病例。对疫苗缺乏信任以及在安排日常活动时未将疫苗接种列为优先事项是拒绝和不依从的重要因素。
要在资源有限的小社区组织成功的高危儿童疫苗接种计划,医疗专业人员提供可靠信息至关重要。公共卫生举措应侧重于缓解家长对疫苗的担忧。此外,确保医生与公共卫生部之间良好合作有助于计划成功实施。最后,让儿科医生参与并使用专门的儿童接种区域有助于与家长和照顾者建立信任。